Patents by Inventor Kay Opperman

Kay Opperman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260309719
    Abstract: Improved sample preparation methods for detecting and/or quantifying host cell proteins in a sample are provided. The methods include contacting a sample with a solid support including an immunoglobulin binding protein at a pH of about 8-10 to produce a sample including the antibody or antibody fragment bound to the solid support. The methods also include contacting the sample including the antibody or antibody fragment bound to the solid support with a protease agent to produce partially digested antibody and target proteins and separating the sample into a first fraction including the antibody or antibody fragment bound to the solid support, and a second fraction including a supernatant including the partially digested target proteins. The methods also include processing the supernatant and detecting the one or more target proteins, for example using mass spectrometry. Compositions and kits for detecting host cell proteins are also provided.
    Type: Application
    Filed: May 24, 2024
    Publication date: October 8, 2026
    Inventors: Jae H. CHOI, Kay OPPERMAN, Bhavin Bharat PATEL
  • Patent number: 12123814
    Abstract: Formulations for extraction and stabilization of G-Protein Coupled Receptors (GPCRs), kits and methods for their use for extracting GPCRs from biological specimens (e.g., cells and tissues), and methods for making such formulations in bulk scale are described. GPCRs extracted from cells and tissues using the described formulations remain in a functional, solubilized form over extended time periods.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: October 22, 2024
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Barbara Kaboord, Joanna Geddes, Christopher Wojewodzki, Kay Opperman, Scott Meier
  • Publication number: 20240252988
    Abstract: Dialysis devices include a frame defined by a plurality of sidewalls that are impermeable to a sample being dialyzed, a pair of dialysis membranes that are each associated with an opposing face of the plurality of sidewalls such that the plurality of sidewalls and the pair of dialysis membranes define a sample chamber, an outer shell surrounding at least a portion of the pair of dialysis membranes, and a cap selectively associated with the sample chamber. The cap can be selectively associated with the sample chamber via an attachment mechanism that is configured to provide aural and/or haptic feedback when the cap forms a tight association with the sample chamber. The cap can be a sensor cap having one or more probes for measuring at least one property of fluid inside and/or outside the sample chamber and a transmitter for transmitting data captured at the probe(s) to a destination device.
    Type: Application
    Filed: March 12, 2024
    Publication date: August 1, 2024
    Inventors: Kay Opperman, Barbara Kaboord, Aaron McBride, Greg Nagy, Sandro Klein, Joanna Geddes
  • Patent number: 11958016
    Abstract: Dialysis devices include a frame defined by a plurality of sidewalls that are impermeable to a sample being dialyzed, a pair of dialysis membranes that are each associated with an opposing face of the plurality of sidewalls such that the plurality of sidewalls and the pair of dialysis membranes define a sample chamber, an outer shell surrounding at least a portion of the pair of dialysis membranes, and a cap selectively associated with the sample chamber. The cap can be selectively associated with the sample chamber via an attachment mechanism that is configured to provide aural and/or haptic feedback when the cap forms a tight association with the sample chamber. The cap can be a sensor cap having one or more probes for measuring at least one property of fluid inside and/or outside the sample chamber and a transmitter for transmitting data captured at the probe(s) to a destination device.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: April 16, 2024
    Assignees: Pierce Biotechnology, Inc., Life Technologies Corporation
    Inventors: Kay Opperman, Barbara Kaboord, Aaron McBride, Greg Nagy, Sandro Klein, Joanna Geddes
  • Publication number: 20200000992
    Abstract: Dialysis devices include a frame defined by a plurality of sidewalls that are impermeable to a sample being dialyzed, a pair of dialysis membranes that are each associated with an opposing face of the plurality of sidewalls such that the plurality of sidewalls and the pair of dialysis membranes define a sample chamber, an outer shell surrounding at least a portion of the pair of dialysis membranes, and a cap selectively associated with the sample chamber. The cap can be selectively associated with the sample chamber via an attachment mechanism that is configured to provide aural and/or haptic feedback when the cap forms a tight association with the sample chamber. The cap can be a sensor cap having one or more probes for measuring at least one property of fluid inside and/or outside the sample chamber and a transmitter for transmitting data captured at the probe(s) to a destination device.
    Type: Application
    Filed: June 28, 2019
    Publication date: January 2, 2020
    Inventors: Kay Opperman, Barbara Kaboord, Aaron McBride, Greg Nagy, Sandro Klein, Joanna Geddes
  • Patent number: 8536323
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: September 17, 2013
    Assignee: Pierce Biotechnology, Inc.
    Inventors: Kay Opperman, Barbara J. Kaboord, Jean-Samuel Schultz, Christopher L. Etienne, Greg Hermanson
  • Publication number: 20110262917
    Abstract: Modified nucleotides, and methods to modify nucleotides with a moiety or label, such as biotin, that permits their detection and results in a modified nucleotide, and methods of use of the modified nucleotide in quantitative and qualitative assays.
    Type: Application
    Filed: April 20, 2011
    Publication date: October 27, 2011
    Applicant: PIERCE BIOTECHNOLOGY, INC.
    Inventors: Kay Opperman, Barbara J. Kaboord, Jean-Samuel Schultz, Christopher L. Etienne, Greg Hermanson